4
Changes in Ownership
Viridian Therapeutics, Inc.\DE Filed Acc 0000899243-23-002075
Chief Medical Officer sold 29,000 shares at an average $37.18 ($1,078,261)
- Chief Medical Officer acquired 29,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Katz Barrett Chief Medical Officer | 2023-01-13 | Option exercise | +4,147 | $23.03 | $95,505 | 4,147 | D |
| Katz Barrett Chief Medical Officer | 2023-01-13 | Sale | −4,147 | $37.01 | $153,480 | 0 | D |
| Katz Barrett Chief Medical Officer | 2023-01-17 | Option exercise | +24,853 | $23.03 | $572,365 | 24,853 | D |
| Katz Barrett Chief Medical Officer | 2023-01-17 | Sale | −24,853 | $37.21 | $924,780 | 0 | D |
| Derivatives | |||||||
| Katz Barrett Chief Medical Officer | 2023-01-13 | Option exercise · Stock Option (Right to Buy) | −4,147 | 291,853 | D | ||
| Katz Barrett Chief Medical Officer | 2023-01-17 | Option exercise · Stock Option (Right to Buy) | −24,853 | 267,000 | D | ||
| Open-market sales · 29,000 sh · avg $37.18 · $1,078,261 | |||||||
Loading xslF345X03/doc4.xml…